Irbesartan lowers blood pressure by blocking a specific receptor that normally causes blood vessels to tighten. It belongs to a class of drugs called angiotensin II receptor blockers, or ARBs, and it works by preventing a powerful hormone called angiotensin II from doing its job. The result is relaxed blood vessels and lower blood pressure, typically from a single daily dose.
The Hormone It Blocks
Your body constantly regulates blood pressure through a chain of chemical signals called the renin-angiotensin system. When your kidneys detect low blood flow, they release an enzyme that eventually produces angiotensin II, one of the most potent blood-vessel-tightening substances your body makes. Angiotensin II latches onto specific docking sites on blood vessel walls called AT1 receptors. Once it binds, two things happen: your blood vessels constrict, and your adrenal glands release a hormone called aldosterone that tells your kidneys to hold onto sodium and water. Both of these effects push blood pressure up.
Irbesartan sits on those AT1 receptors and blocks angiotensin II from binding to them. It does this in a non-competitive way, meaning the drug doesn’t just compete with angiotensin II for the receptor. It locks the receptor down so that even rising levels of angiotensin II can’t overcome the block. With the receptor blocked, blood vessels relax, aldosterone secretion drops, and your kidneys release more sodium and water instead of retaining it.
How It Differs From ACE Inhibitors
ACE inhibitors (like lisinopril or enalapril) work earlier in the same hormonal chain. They prevent angiotensin II from being produced in the first place. But that same enzyme also breaks down a substance called bradykinin, which can irritate airways. Because ACE inhibitors let bradykinin build up, roughly 1 in 10 people who take them develop a persistent dry cough that won’t go away.
Irbesartan sidesteps this problem entirely. It doesn’t interfere with bradykinin breakdown at all. It simply blocks angiotensin II after it’s already been made. This is why ARBs like irbesartan are commonly prescribed as an alternative when someone can’t tolerate the cough from an ACE inhibitor.
How Quickly It Works and How Long It Lasts
After you swallow a tablet, irbesartan reaches its highest concentration in your blood within about 1.5 to 2 hours. At the standard doses of 150 mg or 300 mg, it completely blocks the angiotensin II response within 4 hours. That blockade gradually tapers over the rest of the day, but enough of the drug remains active to maintain partial blood pressure control through a full 24-hour period. The drug’s elimination half-life averages 11 to 15 hours, which is why once-daily dosing is sufficient for most people.
What It’s Prescribed For
Irbesartan (sold under the brand name Avapro) is FDA-approved for two uses. The first and most common is treating high blood pressure. Lowering blood pressure reduces the long-term risk of strokes and heart attacks.
The second approved use is protecting the kidneys in people with type 2 diabetes who already have signs of kidney damage, specifically elevated creatinine levels and significant protein in the urine. This kidney-protective effect goes beyond simple blood pressure control. In a major clinical trial called IRMA-2, patients with type 2 diabetes and early kidney damage who took 300 mg of irbesartan daily were 68% less likely to progress to full-blown kidney disease over two years compared to those on a placebo. Even accounting for differences in blood pressure between the groups, the benefit held up, suggesting irbesartan has a direct protective effect on the kidneys. The drug also reduced the amount of protein leaking into urine by 38% at the higher dose.
Typical Dosing
For high blood pressure, the usual starting dose is 150 mg once a day. If blood pressure isn’t controlled enough after a few weeks, the dose can be increased to 300 mg once daily. Going above 300 mg or splitting it into two daily doses doesn’t provide additional benefit. People who are volume-depleted, for instance from aggressive diuretic use or dialysis, typically start lower at 75 mg to avoid a sharp drop in blood pressure.
For kidney protection in type 2 diabetes, the target dose is 300 mg once daily. Clinical data on lower doses for this purpose is limited, so the full dose is the standard recommendation.
Side Effects to Know About
Because irbesartan reduces aldosterone (the hormone that tells your kidneys to excrete potassium), potassium levels in your blood can rise. This is the most common side effect and is especially pronounced in people who already have kidney problems. In studies of diabetic patients with chronic kidney disease, nearly half experienced elevated potassium levels. In those with normal kidney function, the rate was closer to 30%. This is why routine blood tests to check potassium and kidney function are a standard part of treatment.
Other commonly reported side effects include dizziness (especially when standing up quickly), lightheadedness, and headache. A mild increase in creatinine, a marker of kidney filtration, occurs in 1% to 10% of patients and is usually monitored rather than treated.
Irbesartan carries a boxed warning, the most serious type, regarding use during pregnancy. Drugs that act on the renin-angiotensin system can cause injury and death to a developing fetus, particularly in the second and third trimesters.